Business Description
ABVC BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US0247331079
Description
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -0.37 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -8 | |||||
| Beneish M-Score | -4.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -47.7 | |||||
| 3-Year EBITDA Growth Rate | 29.1 | |||||
| 3-Year EPS without NRI Growth Rate | 15.2 | |||||
| 3-Year FCF Growth Rate | 24.9 | |||||
| 3-Year Book Growth Rate | -9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.63 | |||||
| 9-Day RSI | 45.96 | |||||
| 14-Day RSI | 45.03 | |||||
| 6-1 Month Momentum % | -20.15 | |||||
| 12-1 Month Momentum % | -53.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.34 | |||||
| Quick Ratio | 0.34 | |||||
| Cash Ratio | 0.03 | |||||
| Days Sales Outstanding | 1.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -48 | |||||
| Shareholder Yield % | 28.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.69 | |||||
| Operating Margin % | -1244.2 | |||||
| Net Margin % | -1619.65 | |||||
| FCF Margin % | -352.46 | |||||
| ROE % | -98.3 | |||||
| ROA % | -55.22 | |||||
| ROIC % | -39.18 | |||||
| ROC (Joel Greenblatt) % | -73.79 | |||||
| ROCE % | -72.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.93 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | -1.35 | |||||
| EV-to-Forward-EBIT | 3.07 | |||||
| EV-to-EBITDA | -1.35 | |||||
| EV-to-Revenue | 16.91 | |||||
| EV-to-Forward-Revenue | 1262.84 | |||||
| EV-to-FCF | -4.8 | |||||
| Earnings Yield (Greenblatt) % | -74.07 | |||||
| FCF Yield % | -27.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABVC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ABVC BioPharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.509 | ||
| EPS (TTM) ($) | -0.903 | ||
| Beta | 0.3 | ||
| Volatility % | 59.32 | ||
| 14-Day RSI | 45.03 | ||
| 14-Day ATR ($) | 0.051786 | ||
| 20-Day SMA ($) | 0.544265 | ||
| 12-1 Month Momentum % | -53.46 | ||
| 52-Week Range ($) | 0.4053 - 2.45 | ||
| Shares Outstanding (Mil) | 12.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ABVC BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ABVC BioPharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ABVC BioPharma Inc Frequently Asked Questions
What is ABVC BioPharma Inc(ABVC)'s stock price today?
The current price of ABVC is $0.53. The 52 week high of ABVC is $2.45 and 52 week low is $0.41.
When is next earnings date of ABVC BioPharma Inc(ABVC)?
The next earnings date of ABVC BioPharma Inc(ABVC) is 2025-03-14 Est..
Does ABVC BioPharma Inc(ABVC) pay dividends? If so, how much?
ABVC BioPharma Inc(ABVC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers